Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2002
Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronateDinna N Cruz, Helen M Brickel, John J Wysolmerski, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2022
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney DiseaseKatherine R Tuttle, Leslie Wong, Wendy St Peter, et al.
Kidney & Blood Pressure Research|October 13, 2021
The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network TrialsJochen G Raimann, Christopher T Chan, John T Daugirdas, et al.
Kidney International|July 21, 2022
A randomized controlled pilot trial of anakinra for hemodialysis inflammationLaura M Dember, Adriana Hung, Rajnish Mehrotra, et al.
Blood Purification|January 23, 2016
The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network TrialsJochen G Raimann, Christopher T Chan, John T Daugirdas, et al.
Kidney360|April 4, 2022
The Microbiome and p-Inulin in Hemodialysis: A Feasibility StudyDominic S Raj, Michael B Sohn, David M Charytan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2013
Effects of frequent hemodialysis on ventricular volumes and left ventricular remodelingChristopher T Chan, Tom Greene, Glenn M Chertow, et al.
Kidney360|April 4, 2022
Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot TrialDavid M Charytan, Jesse Y Hsu, Finnian R Mc Causland, et al.
Circulation. Cardiovascular Imaging|February 25, 2012
Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) TrialsChristopher T Chan, Tom Greene, Glenn M Chertow, et al.
Kidney International|November 27, 2018
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trialDavid M Charytan, Jonathan Himmelfarb, T Alp Ikizler, et al.
Pageof 7